Expression of MIP-1γ and TNF-α in PSGL-1 knockout mice
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference [15]
  • | |
  • Cited by
  • | |
  • Comments
    Abstract:

    Objective To investigate the effect of loss of PSGL-1 on routine blood test results in PSGL-1 knockout (PSGL-1-/-) mice, and to detect the expression levels of cytokines IGFBP-6, TNF-α and MIP-1γ mRNA in their peripheral blood.Methods To detect the differences in routine blood test results of normal C57/BL/6 mice and PSGL-1-/- mice. To prepare cDNA from isolated blood mRNA, and to analyze the differences in expression of cytokines TNF-α and MIP-1γ mRNA in peripheral blood of the C57 mice (control) and PSGL-1-/- mice by real-time PCR. Results Compared with the C57 control mice, the 12-week old PSGL-1-/- mice showed significantly increased neutrophils (P<0.05), lymphocytes (P<0.01) and total leukocyte counts (P<0.001), and increased expression levels of TNF-α and MIP-1γ mRNA in the peripheral blood (P<0.05). Conclusions Our findings suggest that the loss of PSGL-1 changes the cell counts of peripheral blood in mice. The up-regulation of cytokines MIP-1γ and TNF-α may influence the immune function of the mice.

    Reference
    [1] Carlow DA, Gossens K, Naus S, et al. PSGL-1 function in immunity and steady state homeostasis[J]. Immunol Rev, 2009, 230(1):75-96.
    [2] Wang HB, Wang JT, Zhang L, et al. P-selectin primes leukocyte integrin activation during inflammation[J]. Nat Immunol, 2007, 8(8):882-92.
    [3] Sultana DA, Zhang SL, Todd SP, et al. Expression of functional P-selectin glycoprotein ligand 1 on hematopoietic progenitors is developmentally regulated[J]. J Immunol, 2012, 188(9):4385-4393.
    [4] Dimitroff CJ, Descheny L, Trujillo N, et al. Identification of Leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells[J]. Cancer Res, 2005, 65(13):5750-5760.
    [5] Blake JA, Richardson JE, Bult CJ, et al. MGD: the Mouse Genome Database[J]. Nucl Acids Res, 2003, 31(1):193-195.
    [6] Bult CJ, Blake JA, Richardson JE, et al. The Mouse Genome Database (MGD): integrating biology with the genome[J]. Nucl Acids Res, 2004, 32:D476-D481.
    [7] Raes G, Ghassabeh GH, Brys L, et al. The metastatic T-cell hybridoma antigen/P-selectin glycoprotein ligand 1 is required for hematogenous metastasis of lymphomas[J]. Int J Cancer, 2007, 121(12):2646-2652.
    [8] Goda MA,Tanaka T, Monden M, et al. Characterization of an apparently conserved epitope in E-and P-selectin identified by dual-specific monoclonal antibodies. Eur J Immonol, 1999, 29:1551-1560.
    [9] Vadas MA, Harlan J. The selection[M]. New York, Harward, 1997: 1.
    [10] Gout S, Huot J. Role of cancer microenvironment in metastasis: focus on colon cancer[J]. Cancer Microenviron, 2008, 1(1):69-83.
    [11] Roy Fleischmann R, Yocum D. Does safety make a difference in selecting the right TNF antagonist[J]. Arthritis Res Ther. 2004; 6(Suppl 2): S12-S18.
    [12] Egberts JH, Cloosters V, Noack A, et al. Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis[J]. Cancer Res, 2008, 68(5):1443-50
    [13] Stathopoulos GT, Kollintza A, Moschos C, et al. Tumor necrosis factor-α promotes malignant pleural effusion[J]. Cancer Res, 2007, 67(20):9825-34
    [14] Scott KA, Moore RJ, Arnott CH, et al. An anti-tumor necrosis factor-α antibody inhibits the development of experimental skin tumors[J]. Mol Cancer Ther, 2003, 2(5):445-451.
    [15] Lara T, Joachim S, Anke S, et al. Wnt signaling regulates transendothelial migration of monocytes[J]. J Leuk Biol. 2006, 79:1306-1313.
    Related
    Cited by
Get Citation
Related Videos

Share
Article Metrics
  • Abstract:4115
  • PDF: 2153
  • HTML: 0
  • Cited by: 0
History
  • Revised:December 11,2013
  • Online: February 28,2014
Article QR Code